Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02646631 · ClinicalTrials.gov registry record · NA
Behavioral and Educational Tools to Improve Epilepsy Care
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT02646631 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 32 participants.
The verdict
NCT02646631, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The long-term goal of this research is to improve seizure control among patients with epilepsy, which has the potential to improve quality of life for thousands of people living with epilepsy and reduce health care utilization, social and economic costs, and epilepsy-related mortalities. Participants who are suffering from epilepsy will be randomized to receive usual care (UC), a smartphone-based self-management intervention called Management of Risks in Epilepsy (MORE), or MORE + telephone-based motivational interviewing (MI). Participants will be followed for 3 months.
Interventions
- OTHER Usual Care
- OTHER Educational Materials
- BEHAVIORAL Management of Risks in Epilepsy (MORE)
- BEHAVIORAL Telephone-based motivational interviewing (MORE+MI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2016-09 |
| Est. Completion | 2017-11-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02646631
The ClinicalTrials.gov registry entry for NCT02646631 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Usual Care is the first listed.
NCT02646631 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02646631 about?
NCT02646631 is a clinical study titled "Behavioral and Educational Tools to Improve Epilepsy Care". The long-term goal of this research is to improve seizure control among patients with epilepsy, which has the potential to improve quality of life for thousands of people living with epilepsy and reduce health care utilization, social and economic costs, and epilepsy-related mortalities. Participant...
What is the current status of trial NCT02646631?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2016-09. Estimated completion is 2017-11-20.
What interventions are being tested in trial NCT02646631?
The interventions under investigation include: Usual Care (OTHER), Educational Materials (OTHER), Management of Risks in Epilepsy (MORE) (BEHAVIORAL), Telephone-based motivational interviewing (MORE+MI) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02646631?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.